Medical Advocates
HIV Infection/Disease
  Pre-Exposure Prophylaxis
General Reports
 Special Populations
 Ethical Challenges
Drugs








 
HIV Prevention Main Page Main New/Newsworthy Home Page

Last Update:  January 29, 2012
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
     
      Journal Papers, Abstracts, and Commentaries    
 
 
FULL-TEXT ARTICLE
 Attitudes and Acceptance of Oral and Parenteral HIV Preexposure Prophylaxis among
Potential User Groups: A Multinational Study.
Eisingerich AB, Wheelock A, Gomez GB,  et al
PLoS One. 2012;7(1):e28238.
 Paper

Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?
Hurt CB, Eron JJ Jr, Cohen MS.
Clin Infect Dis. 2011 Oct 5
 Abstract

FULL-TEXT ARTICLE
 2011 HIV Pre-Exposure Prophylaxis (PrEP)—A Quantitative Ethics Appraisal.
Kokolo MB, Fergusson DA, Cameron DW,  et  al
PLoS ONE 6(8): e22497.
Paper

FULL-TEXT ARTICLE
 Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout
of Antiretroviral Pre-Exposure Prophylaxis (PrEP).
Abbas UL, Hood G, Wetzel AW, Mellors JW.
 PLoS One. 2011 Apr 15;6(4):e18165
 Paper

A US Policy Perspective on Oral Preexposure Prophylaxis for HIV.
Leibowitz A, Parker K, Rotheram-Borus M.
Am J Public Health. 2011 Apr 14
 Abstract

Pre-Exposure Prophylaxis and the Promise of Combination Prevention Approaches.
Buchbinder SP, Liu A.
 AIDS Behav. 2011 Feb 18.
Abstract

Oral Preexposure Anti-HIV Prophylaxis for High-Risk U.S. Populations: Current
Considerations in Light of New Findings.
Myers GM, Mayer KH.
AIDS Patient Care STDS. 2011 Feb;25(2):63-71.
 Abstract

FULL-TEXT ARTICLE
 Oral Preexposure Prophylaxis for HIV - Another Arrow in the Quiver?
Michael NL.
N Engl J Med. 2010 Nov 23
 Paper

FULL-TEXT ARTICLE
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Grant RM, Lama JR, Anderson PL, et al
 N Engl J Med. 2010 Nov 23.
Paper

FULL-TEXT ARTICLE
 Evaluating the Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) and Its Impact on
HIV-1 Transmission in South Africa.
Pretorius C, Stover J, Bollinger L, Bacaër N, Williams B.
 PLoS One. 2010 Nov 5;5(11):e13646.
 Paper

The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.
van de Vijver DA, Boucher CA.
 Curr Opin Infect Dis. 2010 Sep 16.
 Abstract

Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis
Implementation in Clinical Practice
Underhill K, Operario D, Skeer M, et al
 J Acquir Immune Defic Syndr. 2010 Sep;55(1):8-13
 Abstract

Pre-exposure Prophylaxis State of the Science: Empirical Analogies for Research
and Implementation.
Golub SA, Operario D, Gorbach PM
 Curr HIV/AIDS Rep. 2010 Sep 1.
Abstract

Planning for pre-exposure prophylaxis to prevent HIV transmission:
challenges and opportunities.
Kim SC, Becker S, Dieffenbach C, et al
J Int AIDS Soc. 2010 Jul 12;13(1):24
 Abstract

HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.
Supervie V, García-Lerma JG, Heneine W, Blower S.
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12381-6
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Pre-exposure prophylaxis in HIV - a vision or soon a reality?
Reuter S, Meyer D, Knechten H, et al
Dtsch Med Wochenschr. 2009 Dec;134(50):2582-2584.
 Abstract

Oral pre-exposure prophylaxis for HIV prevention.
García-Lerma JG, Paxton L, Kilmarx PH, Heneine W.
Trends Pharmacol Sci. 2009 Dec 4.
Abstract

The performative function of expectations in translating treatment to prevention:
The case of HIV pre-exposure prophylaxis, or PrEP.
Rosengarten M, Michael M.
 Soc Sci Med. 2009 Aug 18.
 Abstract

HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes,
and Cost-Effectiveness.
Paltiel AD, Freedberg KA, Scott CA, et al
 Clin Infect Dis. 2009 Feb 1
 Abstract
 
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.
Okwundu CI, Okoromah CA. 
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007189
 Abstract
 
Antiretrovirals to Prevent HIV Infection: Pre- and Postexposure Prophylaxis.
Gay CL, Cohen MS.  
Curr Infect Dis Rep. 2008 Jul;10(4):323-31.
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
 We Must Not Let Protestors Derail Trials of Pre-Exposure Prophylaxis for HIV
Lange JMA
 PLOS MedicineVol2 Issue 9 Sep 2005
 Paper
 
FULL-TEXT ARTICLE
 The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong?
Singh J,  Mills EJ
 PLOS Medicine Vol2 Issue 9 Sep 2005
 Paper
 
FULL-TEXT ARTICLE
Media reporting of tenofovir trials in Cambodia and Cameroon.
Mills E, Rachlis B, Wu P, et al
BMC Int Health Hum Rights.  2005 Aug 24;5:6.
 Paper
 
FULL-TEXT ARTICLE
Pre-exposure chemoprophylaxis for HIV: it is time.
Smith SM.
Retrovirology. 2004 Jul 6;1(1):16.
 Paper
 
 
     Conference Reports, Abstracts, and Posters 
 
 
POSTER
 Generation of trust between study staff and trial participants enhances participants´ compliance to
study procedures in a PrEP trial in the Andes
P. Goicochea, L. Vargas J. Lama, et al  
(5th IAS Conference)
PDF Poster
 
POSTER
 Screening, enrollment, and follow-up of injecting drug users in an HIV pre-exposure prophylaxis trial
in Bangkok
M. Martin, S. Vanichseni, P. Suntharasamai 
(5th IAS Conference)
 PDF Poster
 

POSTER
Who pays if PrEP works? Potential challenges to PrEP delivery in the United States
K. Fisher, E. Bass, C. Feuer, et al 5th IAS Conference
(5th IAS Conference}
 PDF Poster

Influence of potential symptoms and perceived efficacy on the willingness to use HIV
Pre-Exposure Prophylaxis (PrEP) among Boston area men who have sex with men (MSM)
K. Mayer, C. Johnson, M. Mimiaga, et al
(5th IAS Conference}
 Abstract

POSTER
 Barriers and Facilitators to Pre-exposure Prophylaxis Adherence in the Pre-Exposure
Prophylaxis Initiative:
A Prevention Trial that Started in 3 Andean Cities
P Goicochea, R Grant, L Vargas, et al
 (16 CROI)
PDF Poster     Abstract
 

POSTER
 The Paradox of Pre-exposure Prophylaxis: Effects on Incidence and Transmitted Resistance i
n San Francisco
V Supervie, G García-Lerma, W Heneine, S Blower
 (16 CROI)
PDF Poster     Abstract
 
Pre-Exposure Prophylaxis: Could It Work?
S Hillier
 (16 CROI)
 Abstract
 
Pre-exposure Prophylaxis with Antiretrovirals as a Universal Approach to Prevent HIV Transmission
P Denton, J Estes, and V Garcia
(16 CROI)
Abstract
 

What is the role of community advocacy in future pre-exposure prophylaxis (PrEP) research?
Halima Y, Kort R
 (4th IAS Conference)
 Abstract
 
Antiretroviral therapy for prevention of transmission of HIV-1
 MS Cohen
(8th Int Congress on Drug Therapy in HIV Infection)
 Abstract
 
Antiretroviral Therapy to Prevent Sexual Transmission of HIV
M Cohen 
(13 CROI)
 Abstract
 
Cost-effectiveness Analysis of ART for Pre-exposure Prophylaxis
A Hill, M Youle, C Boucher 
(13 CROI)
 Abstract
Special Populations
Women    
Discordant Couples
 
      Journal Papers, Abstracts, and Commentaries    
 
 
What's Love Got to Do With It? Explaining Adherence to Oral Antiretroviral Pre-exposure
Prophylaxis (PrEP) for HIV Serodiscordant Couples.
Ware NC, Wyatt MA, Haberer JE,  et al
 J Acquir Immune Defic Syndr. 2012 Jan 19
 Abstract

Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
Anglemyer A, Rutherford GW, Baggaley RC, et al
Cochrane Database Syst Rev. 2011 Aug 10;(8):CD009153
 Abstract

Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
Anglemyer A, Rutherford GW, Egger M, Siegfried N.
Cochrane Database Syst Rev. 2011 May 11;5:CD009153.
 Abstract
 
        Conference Reports, Abstracts, and Posters
 
  Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to
conceive a child
Vernazza P, Brenner I, Graf I, et al
 (4th IAS Conference)
 Abstract
 
IDUs
 
      Journal Papers, Abstracts, and Commentaries    
 
  POSTER
 HIV-associated risk behavior among injecting drug users participating in an HIV pre-exposure
prophylaxis trial in Bangkok
S. Vanichseni, M. Martin, P. Suntharasamai, et al 
(5th IAS Conference)|
 PDF Poster

MSM
 
      Journal Papers, Abstracts, and Commentaries    
 
 
Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious
population of men who have sex with men.
Dolling D, Phillips A, Delpech V,  et al
HIV Med. 2011 Dec 12.
Abstract

Pre-exposure prophylaxis and the promise of combination prevention approaches.
Buchbinder SP, Liu A.
AIDS Behav. 2011 Apr;15 Suppl 1:S72-9.
 Abstract

A WEEK-IN-REVIEW-FEATURED REPORT
FULL-TEXT ARTICLE
 Interim Guidance: Preexposure Prophylaxis for the Prevention of HIV Infection in Men Who Have
Sex with Men.
Centers for Disease Control and Prevention (CDC
MWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):65-68.
 Paper

Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men.
Golub SA, Kowalczyk W, Weinberger CL, Parsons JT.  
J Acquir Immune Defic Syndr. 2010 Aug 15;54(5):548-55
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Preexposure Prophylaxis and Predicted Condom Use Among High-Risk Men
Who Have Sex With Men.
Golub SA, Kowalczyk W, Weinberger CL, Parsons JT.
J Acquir Immune Defic Syndr. 2010 May 27
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Use of Non-Occupational Post-Exposure Prophylaxis does not Lead to an
Increase in High Risk Sex Behaviors in Men Who have Sex with Men Participating
in the EXPLORE Trial.
Donnell D, Mimiaga MJ, Mayer K, et al 
AIDS Behav. 2010 May 19.
 Abstract

     Conference Reports, Abstracts, and Posters
 
 
Influence of potential symptoms and perceived efficacy on the willingness to use HIV
Pre-Exposure Prophylaxis (PrEP) among Boston area men who have sex with men (MSM)
K. Mayer, C. Johnson, M. Mimiaga, et al 
(5th IAS Conference
 Abstract

Oral or rectal chemoprophylaxis to prevent HIV transmission: what do at risk men who have sex
with men (MSM) know and want?
Mayer K, Dolezal C, Carballo-Dieguez A, et al
 (4th IAS Conference)
 Abstract
 
Willingness to participate in a HIV pre-exposure prophylaxis efficacy trial among high risk men who
have sex with men in the Andean region
 Lama JR, Guanira J, Goicochea P
 (4th IAS Conference)
 Abstract
 
Modeling the potential impact of HIV chemoprophylaxis strategies among men who have sex with
men in the United States: HIV infections prevented and cost-effectiveness
Desai K., McGreevey W.P., Ackers M.L., et al
 (XVI International AIDS Conference)
 Abstract

Low levels of pre-exposure prophylaxis awareness and use among HIV-negative/unknown gay/
bisexual men: San Francisco Bay Area residents, circuit party attendees, and clients of an urban
STD clinic
A. Liu, S. Wheeler, E. Vittinghoff, et al 
(XVI International AIDS Conference)
 Abstract

HIV Pre- and Post- Exposure Prophylaxis Among Bathhouse Patrons
DDaskalakis, K T. Bernstein, R Hagerty, et al 
(2006 National STD Prevention Conference0
 Abstract
 
Knowledge and Use of Pre-Exposure Prophylaxis Among Attendees of Minority Gay
Pride Events, 2004
Kellerman S., Hutchinson A., Begley E., et al
 ($rd IAS)
 Abstract
 
Sexworkers

     Conference Reports, Abstracts, and Posters

 
Factors influencing adherence to pills for pre-exposure prophylaxis: lessons learned from a phase
2 trial
Lawoyin T., Alleman P., Guest G., MacQueen K.
 (XVI International AIDS Conference)
 Abstract
Ethical Challenges
     

     Journal Papers, Abstracts, and Commentaries 

  Tenofovir trials raise ethical issues.
Mills E.
HIV AIDS Policy Law Rev. 2005 Aug;10(2):31-2.
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
  POSTER
 Ethical appraisal of HIV oral pre-exposure prophylaxis trials: literature review and
proposed tool
M.B. Kokolo 
(5th IAS Conference)
PDF Poster     Abstract
Drugs
     
Nevirapine

     Journal Papers, Abstracts, and Commentaries 
 
  A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission
in uninfected subjects at high risk.
 Jackson JB, Barnett S, Piwowar-Manning E, et al.
AIDS 2003 Mar 7;17(4):547-53
 Abstract
 
Tenofovir

       Journal Papers, Abstracts, and Commentaries 
 
 
Acceptability of PrEP for HIV Prevention Among Women at High Risk for HIV.
 Guest G, Shattuck D, Johnson L,  et  al
J Womens Health (Larchmt). 2010 Mar 8.
Abstract

FULL TEXT ARTICLE
 Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2,
Double-Blind,Randomized, Placebo-Controlled Trial.
Peterson L, Taylor D, Roddy R, et al
PLoS Clin Trials. 2007 May 25;2(5):e27.
 Paper

Tenofovir trials raise ethical issues.
Mills E.
HIV AIDS Policy Law Rev. 2005 Aug;10(2):31-2.
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
 
Factors influencing adherence to pills for pre-exposure prophylaxis: lessons learned from a phase
2 trial
Lawoyin T., Alleman P., Guest G., MacQueen K.
 XVI International AIDS Conference)
 Abstract
 
HIV prevention using tenofovir: community participation in the formative phase of a HIV prevention
trial in Cambodia
Pisith P., Roberts J., Sim S.,  et al
 (XVI International AIDS Conference)
 Abstract
 
Addressing HIV prevention trial challenges through sociobehavioral research: Cameroon’s tenofovir
trial
Nyiama T.A., Mack N., MacQueen K., et al
 (XVI International AIDS Conference)
 Abstract
 
Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana:
a simple mathematical modelling approach
Smith D., Kebaabetswe P., Disasi K., et al
 (XVI International AIDS Conference)
 Abstract
 
Participant experiences of the tenofovir HIV prevention trial in Nigeria and Cameroon: implications
for recruitment and retention
Guest G., Alleman P., Lawoyin T., et al
 (XVI International AIDS Conference)
 Abstract
 
Overcoming the challenges of prevention research: lessons learned from the tenofovir pre-exposure
prophylaxis trials
Halima Y.
(XVI International AIDS Conference)
 Abstract
 
Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana:
a simple mathematical modelling approach
 Smith D., Kebaabetswe P., Disasi K., et al
 (XVI International AIDS Conference)
 Abstract
 
Findings from a double-blind, randomized, placebo-controlled trial of tenofovir disoproxil fumarate
(TDF) for prevention of HIV infection in women
 L. Peterson, D. Taylor, EEK. Clarke, et al 
(XVI International AIDS Conference)
 Abstract

HIV Prevention Main Page Main New/Newsworthy Home Page

HIV Infection/Disease:
Pre-Exposure Prophylaxis